5.2.0.0 Preeclamp­sia and As­pirin

Rec­om­men­da­tion

14.12 Women with type 1 or type 2 di­a­betes should be pre­scribed low-‍dose as­pirin 60–150 mg/‍day (usual dose 81 mg/‍day) from the end of the first trimester until the baby is born in order to lower the risk of preeclamp­sia. A

Di­a­betes in preg­nan­cy is as­so­ci­at­ed with an in­creased risk of preeclamp­sia (68). Based upon the re­sults of clin­i­cal tri­als, the U.S. Pre­ven­tive Ser­vices Task Force rec­om­mends the use of low-‍dose as­pirin (81 mg/‍day) as a pre­ventive med­i­ca­tion after 12 weeks of ges­ta­tion in women who are at high risk for preeclamp­sia (69). A cost-‍benefit anal­y­sis has con­clud­ed that this ap­proach would re­duce mor­bid­i­ty, save lives, and lower health care costs (70).